CA2868444A1 - Combination treatment comprising sulphated glycosaminoglycans for inducing labor - Google Patents

Combination treatment comprising sulphated glycosaminoglycans for inducing labor Download PDF

Info

Publication number
CA2868444A1
CA2868444A1 CA2868444A CA2868444A CA2868444A1 CA 2868444 A1 CA2868444 A1 CA 2868444A1 CA 2868444 A CA2868444 A CA 2868444A CA 2868444 A CA2868444 A CA 2868444A CA 2868444 A1 CA2868444 A1 CA 2868444A1
Authority
CA
Canada
Prior art keywords
chemically modified
heparan sulfate
heparin
modified heparin
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2868444A
Other languages
English (en)
French (fr)
Inventor
Gunvor Ekman-Ordeberg
Anders Malmstrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dilafor AB
Original Assignee
Dilafor AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dilafor AB filed Critical Dilafor AB
Publication of CA2868444A1 publication Critical patent/CA2868444A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2868444A 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor Abandoned CA2868444A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261615398P 2012-03-26 2012-03-26
US61/615,398 2012-03-26
PCT/SE2013/050332 WO2013147689A1 (en) 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Publications (1)

Publication Number Publication Date
CA2868444A1 true CA2868444A1 (en) 2013-10-03

Family

ID=49260783

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2868444A Abandoned CA2868444A1 (en) 2012-03-26 2013-03-25 Combination treatment comprising sulphated glycosaminoglycans for inducing labor

Country Status (15)

Country Link
US (1) US20150045322A1 (enExample)
EP (1) EP2830635A4 (enExample)
JP (1) JP6234989B2 (enExample)
CN (1) CN104203256B (enExample)
AU (1) AU2013240597A1 (enExample)
CA (1) CA2868444A1 (enExample)
HK (1) HK1203369A1 (enExample)
IL (1) IL234689A0 (enExample)
MX (1) MX2014011505A (enExample)
MY (1) MY175743A (enExample)
RU (1) RU2014143017A (enExample)
SG (1) SG11201406119WA (enExample)
UA (1) UA117908C2 (enExample)
WO (1) WO2013147689A1 (enExample)
ZA (1) ZA201406901B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2794665T3 (da) 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
US20150099703A1 (en) * 2012-05-08 2015-04-09 Dilafor Ab Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
US12502403B2 (en) 2020-02-17 2025-12-23 Dilafor Ab Tafoxiparin for the treatment of preeclampsia
CA3255831A1 (en) 2022-05-03 2023-11-09 Dilafor Ab NEW MEDICAL USE OF TAFOXIPARIN
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5993810A (en) * 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
US8445436B2 (en) * 2007-12-03 2013-05-21 Florida State University Research Foundation, Inc. Oxytocin and melatonin compositions and associated methods for inducing labor
WO2013081896A1 (en) * 2011-11-28 2013-06-06 Corning Incorporated Robust optical touch-screen systems and methods using a planar transparent sheet
DK2794665T3 (da) * 2011-12-19 2018-01-29 Dilafor Ab Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf

Also Published As

Publication number Publication date
JP2015511664A (ja) 2015-04-20
WO2013147689A1 (en) 2013-10-03
JP6234989B2 (ja) 2017-11-22
UA117908C2 (uk) 2018-10-25
MY175743A (en) 2020-07-07
CN104203256A (zh) 2014-12-10
IL234689A0 (en) 2014-11-30
MX2014011505A (es) 2014-12-05
US20150045322A1 (en) 2015-02-12
HK1203369A1 (en) 2015-10-30
CN104203256B (zh) 2017-11-24
SG11201406119WA (en) 2014-11-27
RU2014143017A (ru) 2016-05-20
AU2013240597A1 (en) 2014-10-16
EP2830635A4 (en) 2016-03-16
EP2830635A1 (en) 2015-02-04
ZA201406901B (en) 2017-09-27

Similar Documents

Publication Publication Date Title
US20150057226A1 (en) Method for treatment of labor arrest
US8524688B2 (en) Use of sulfated glycosaminoglycans for establishing effective labor in women
KR102135485B1 (ko) 반복 다이사카라이드 단위를 포함하는 비-항응고 글리코스아미노글리칸 및 이의 의학적 용도
US20150045322A1 (en) Combination treatment comprising sulphated glycosaminoglycans for inducing labor
US20150099703A1 (en) Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent
EP4272749A1 (en) New medical use of tafoxiparin

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190326